Rituximab is a laboratory manufactured antibody that targets the cells in our bodies that produce antibodies. This was genetically engineered and is the first monoclonal antibody to be approved by the FDA for the treatment of cancer. The current indication…
- Главная страница
- О нас
- Живущих с P/P
- Научные исследования
- Принять участие
- Новости & Информация о
- Discussion Forums
